Related references
Note: Only part of the references are listed.Platinum-based drugs: past, present and future
Shahana Dilruba et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems
Carolin Muegge et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding
Carolin Muegge et al.
INORGANIC CHEMISTRY (2015)
Interactions of carboplatin and oxaliplatin with proteins: Insights from X-ray structures and mass spectrometry studies of their ribonuclease A adducts
Luigi Messori et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Platinated oligomers of bovine pancreatic ribonuclease: Structure and stability
Delia Picone et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions
Carolin Mugge et al.
DALTON TRANSACTIONS (2014)
Ruthenium metalation of proteins: the X-ray structure of the complex formed between NAMI-A and hen egg white lysozyme
Luigi Messori et al.
DALTON TRANSACTIONS (2014)
A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds
Benoit Bertrand et al.
DALTON TRANSACTIONS (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Interactions between Anticancer trans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts of trans-(Dimethylamino)(methylamino)dichloridoplatinum(II)
Luigi Messori et al.
INORGANIC CHEMISTRY (2014)
Cisplatin Binding to Proteins: Molecular Structure of the Ribonuclease A Adduct
Luigi Messori et al.
INORGANIC CHEMISTRY (2014)
New Water-Soluble Ruthenium(II) Terpyridine Complexes for Anticancer Activity: Synthesis, Characterization, Activation Kinetics, and Interaction with Guanine Derivatives
Ana Rilak et al.
INORGANIC CHEMISTRY (2014)
In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer
Malgorzata Frik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
In vivo anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(η6-p-cymene)-Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
Andrea Weiss et al.
CHEMICAL SCIENCE (2014)
Investigating the Ruthenium Metalation of Proteins: X-ray Structure and Raman Microspectroscopy of the Complex between RNase A and AziRu
Alessandro Vergara et al.
INORGANIC CHEMISTRY (2013)
Next-Generation Anticancer Metallodrugs
Seiji Komeda et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Challenges and Opportunities in the Development of Organometallic Anticancer Drugs
Christian G. Hartinger et al.
ORGANOMETALLICS (2012)
Incorporation of organometallic Ru complexes into apo-ferritin cage
Yusuke Takezawa et al.
DALTON TRANSACTIONS (2011)
Metal-based antitumour drugs in the post-genomic era: what comes next?
Gianni Sava et al.
DALTON TRANSACTIONS (2011)
Organometallic ruthenium-based antitumor compounds with novel modes of action
Wee Han Ang et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2011)
The X-ray Structure of the Adduct between NAMI-A and Carbonic Anhydrase Provides Insights into the Reactivity of this Metallodrug with Proteins
Angela Casini et al.
CHEMMEDCHEM (2010)
Metabolization of [Ru(η6-C6H5CF3)(pta)Cl2]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligand
Alexander E. Egger et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model
A. Bergamo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Bioorganometallic chemistry-from teaching paradigms to medicinal applications
Christian G. Hartinger et al.
CHEMICAL SOCIETY REVIEWS (2009)
KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
Christian G. Hartinger et al.
CHEMISTRY & BIODIVERSITY (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole):: Aquation, redox properties, protein binding, and antiproliferative activity
Michael Groessl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Direct cellular responses to platinum-induced DNA damage
Yongwon Jung et al.
CHEMICAL REVIEWS (2007)
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes
C Scolaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Free exchange across cells, and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A (imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate) on KB tumor cells
F Frausin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
S Kapitza et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Half-sandwich arene ruthenium(II)-enzyme complex
IW McNae et al.
CHEMICAL COMMUNICATIONS (2004)
Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A
G Sava et al.
EUROPEAN JOURNAL OF CANCER (2004)
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl4(DSMO)(Im)] (NAMI-A) with the proteins and the weak interaction with nucleobases
M Ravera et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Ruthenium antimetastatic agents
E Alessio et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin
A Bergamo et al.
INVESTIGATIONAL NEW DRUGS (2003)
A spectroscopic study of the reaction of NAMI, a novel ruthenium(III) anti-neoplastic complex, with bovine serum albumin
L Messori et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
